leisure time -WSS

leisure time

author：entertainment 2025-10-01 18:23:09 - browse：4879

Warning sign illustration made of 0s and 1s. -- first opinion coverage from sTAT — Adobe

Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care.

The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health Information Technology.

The agency wants to require developers of electronic health records and other health software to provide users with details about the training and testing of predictive models that draw data from their systems, or are hosted within them. It also wants developers to assess and publicly disclose potential risks and create a way for clinicians and other users to report problems.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Listen: PBM conflicts, RSV vaccines, & the future of flu season

focus

WSS

When is a doctor not a doctor? Try when patients address women doctors

4th of July breaks record for highest global temperature ever measured

Traditional Chinese medicine benefits explored in new JAMA study

Grail is spending more than ever lobbying Congress

Readout Newsletter: What happened with Sarepta's Duchenne data

FDA has safety concerns on CRISPR

leisure time

leisure time

explore

Psychedelics group wrestles with new pharma identity

Chimpanzees, like humans and whales, get menopause: Study

Guidelines to prevent youth baseball injuries need more muscle

Testing for cancer recurrence creates a new limbo for patients

New air purifier tech could be key to improving indoor air quality

Medtronic CEO on promising devices for diabetes, hypertension

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Malaria cases in Florida and Texas: Here’s what you need to know

Why Sanofi got shellacked over its spinoff

focus

Grail is spending more than ever lobbying Congress

Diversifying clinical trials isn't enough to close racial gaps: study

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Meta looks to target Twitter with a rival app called Threads

Meta looks to target Twitter with a rival app called Threads

explore

focus

entertainment

leisure time